S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Revelation Biosciences (REVB) Short Interest Ratio & Short Volume

$2.15
+0.24 (+12.57%)
(As of 04/17/2024 ET)

Revelation Biosciences Short Interest Data

Current Short Volume
32,800 shares
Previous Short Volume
32,800 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$89,872.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
March 31, 2024
Outstanding Shares
1,630,000 shares
Float Size
393,500 shares
Short Percent of Float
8.34%
Today's Trading Volume
124,049 shares
Average Trading Volume
341,237 shares
Today's Volume Vs. Average
36%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Revelation Biosciences ?

Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

REVB Short Interest Over Time

REVB Days to Cover Over Time

REVB Percentage of Float Shorted Over Time

Revelation Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202432,800 shares $89,872.00 No Change8.3%0.1 $2.74
3/15/202432,800 shares $79,048.00 -31.5%8.3%0.1 $2.41
2/29/202447,900 shares $174,835.00 +32.7%12.3%0.1 $3.65
2/15/202436,100 shares $109,022.00 -70.0%9.2%0.1 $3.02
1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80
1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22
12/31/2023451,700 shares $226,166.19 +4.7%7.3%6.7 $0.50
12/15/2023431,400 shares $237,701.40 +1,878.9%7.0%7.2 $0.55
11/30/202321,800 shares $15,763.58 -29.5%0.4%0.4 $0.72
11/15/202330,900 shares $19,476.27 +134.1%0.5%0.6 $0.63
10/31/202313,200 shares $7,933.20 -50.6%0.2%0.2 $0.60
10/15/202326,700 shares $18,206.73 +69.0%0.4%0.4 $0.68
9/30/202315,800 shares $10,892.52 +79.6%0.3%0.2 $0.69
9/15/20238,800 shares $6,688.00 +27.5%0.1%0.1 $0.76
8/31/20236,900 shares $4,637.49 -11.5%0.1%0.1 $0.67
8/15/20237,800 shares $5,588.70 +14.7%0.1%0.1 $0.72
7/31/20236,800 shares $5,576.68 -26.9%0.1%0 $0.82
7/15/20239,300 shares $7,786.89 -35.9%0.2%0 $0.84
6/30/202314,500 shares $13,735.85 -74.6%0.3%0 $0.95
6/15/202357,000 shares $63,270.00 -39.8%1.0%0.1 $1.11
5/31/202394,700 shares $99,435.00 +38.5%1.6%0.1 $1.05
5/15/202368,400 shares $77,292.00 -26.8%1.2%0.1 $1.13
4/30/202393,400 shares $100,872.00 -44.9%2.2%0.1 $1.08
3/31/2020100 shares $2,334.00 -90.0%N/A0 $23.34
3/13/20201,000 shares $25,500.00 -9.1%N/A0.2 $25.50
2/28/20201,100 shares $37,609.00 +450.0%N/A0.1 $34.19
2/14/2020200 shares $7,470.00 -71.4%N/A0 $37.35
1/31/2020700 shares $25,305.00 +600.0%N/A0.1 $36.15
1/15/2020100 shares $3,832.00 No ChangeN/A0 $38.32
12/31/2019100 shares $3,940.00 -83.3%N/A0 $39.40

REVB Short Interest - Frequently Asked Questions

What is Revelation Biosciences' current short interest?

Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 32,800 shares of REVB short. 8.34% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest.

What is a good short interest percentage for Revelation Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.34% of Revelation Biosciences' floating shares are currently sold short.

What is Revelation Biosciences' float size?

Revelation Biosciences currently has issued a total of 1,630,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 393,500 shares.

How does Revelation Biosciences' short interest compare to its competitors?

8.34% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Revelation Biosciences: Phio Pharmaceuticals Corp. (0.47%), 60 Degrees Pharmaceuticals, Inc. (0.75%), Aravive, Inc. (1.81%), TransCode Therapeutics, Inc. (0.61%), Onconetix, Inc. (3.17%), Atreca, Inc. (0.37%), Altamira Therapeutics Ltd. (28.13%), Notable Labs, Ltd. (0.05%), CNS Pharmaceuticals, Inc. (0.49%), Agile Therapeutics, Inc. (12.68%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Revelation Biosciences stock?

Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Revelation Biosciences?

A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further.

How often is Revelation Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:REVB) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners